Region:Asia
Author(s):Geetanshi
Product Code:KRAE1976
Pages:94
Published On:February 2026

By Source:The market is segmented into two primary sources: Hemp and Marijuana. Hemp is increasingly favored for its versatility in various products, including textiles and food, while Marijuana is primarily sought after for its psychoactive and therapeutic properties. The demand for both sources is driven by consumer preferences and the expanding range of applications in health and wellness.

By Derivatives:This segmentation includes CBD, THC, and Others. CBD products are gaining traction due to their therapeutic benefits without the psychoactive effects, while THC remains popular for recreational use. The 'Others' category encompasses various cannabis-infused products, reflecting the growing innovation in the market.

The Australia Legal Cannabis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Cann Group Limited, AusCann Group Holdings Ltd, Zelira Therapeutics, Bod Australia, Althea Group Holdings Limited, THC Global Group Limited, MGC Pharmaceuticals Ltd, Ecofibre Limited, Little Green Pharma, Botanix Pharmaceuticals, Incannex, Epsilon, Medlab Clinical Ltd, Creso Pharma Limited, Harvest One Cannabis Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Australian legal cannabis market appears promising, driven by ongoing legislative reforms and increasing consumer acceptance. As more states consider legalization and the medical community recognizes cannabis's therapeutic benefits, the market is expected to see a surge in product innovation. Additionally, advancements in cultivation technology and sustainable practices will likely enhance production efficiency, positioning Australia as a competitive player in the global cannabis market landscape.
| Segment | Sub-Segments |
|---|---|
| By Source | Hemp Marijuana |
| By Derivatives | CBD THC Others |
| By Cultivation Method | Indoor Cultivation Greenhouse Cultivation Outdoor Cultivation |
| By End-Use | Medical Use Recreational Use Industrial Use |
| By Geographic Region | Australia Capital Territory & New South Wales Victoria & Tasmania Queensland Western Australia Northern Territory & Southern Australia |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Recreational Cannabis Consumers | 150 | Adult Consumers, Cannabis Enthusiasts |
| Medical Cannabis Patients | 100 | Patients with Prescriptions, Healthcare Providers |
| Cannabis Retailers | 80 | Store Managers, Owners of Dispensaries |
| Cultivators and Producers | 70 | Farm Owners, Production Managers |
| Regulatory Bodies and Policy Makers | 50 | Government Officials, Legal Advisors |
The Australia Legal Cannabis Market is valued at approximately USD 860 million, reflecting significant growth driven by increasing acceptance of cannabis for medical use and a rising consumer base for recreational products.